The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients-Reference-Cited by-同舟云学术

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients

Published:2018-01-15 Issue:1 Volume:50 Page:19-29
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Liu Li-Ting,Chen Qiu-Yan,Tang Lin-Quan,Guo Shan-Shan,Guo Ling,Mo Hao-Yuan,Chen Ming-Yuan,Zhao Chong,Guo Xiang,Qian Chao-Nan,Zeng Mu-Sheng,Bei Jin-Xin,Tan Jing,Chen Shuai,Hong Ming-Huang,Shao Jian-Yong,Sun Ying,Ma Jun,Mai Hai-Qiang

Funder

National Natural Science Foundation of China

Guangzhou Science and Technology Program key projects

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-2016-595.pdf

Reference32 articles.

1. The prevalence and prevention of nasopharyngeal carcinoma in China

2. Nasopharyngeal carcinoma

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

4. Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

5. Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial;Journal of Clinical Oncology;2024-06-10

3. Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma;Cancers;2024-05-30

4. Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study;Radiotherapy and Oncology;2024-05

5. Immunological effects of radiopharmaceutical therapy;Frontiers in Nuclear Medicine;2024-04-04